Pre‑operative Hemoglobin Assessment and Management for Elective Surgery

Timing of Assessment

• Measure hemoglobin at least 28 days before elective surgery to allow sufficient time for investigation and treatment of anemia, aiming for WHO normal values (≥13 g/dL men, ≥12 g/dL women) while permitting lower thresholds based on surgical risk and cardiovascular comorbidities【1】【2】.
• For high‑risk procedures or patients with known anemia risk factors (advanced age, diabetes, heart failure, chronic inflammatory disease), screen earlier than 28 days to provide additional lead time for correction【1】【2】.

Hemoglobin Targets by Surgical Risk

Low‑ to Moderate‑Risk Surgery (expected blood loss < 500 mL)

• Target hemoglobin within the normal WHO range (≥13 g/dL men, ≥12 g/dL women) to optimise outcomes【1】【2】.

High‑Risk Surgery (expected blood loss > 500 mL) – not directly cited; omitted per instructions.

Special Populations

Patients with Cardiovascular Disease

• Maintain pre‑operative hemoglobin ≥10 g/dL; values of 6–9 g/dL are linked to a 12‑fold increase in mortality compared with patients without cardiovascular disease【3】.
• A hematocrit <28 % (approximately hemoglobin <9.3 g/dL) is significantly associated with peri‑operative myocardial ischemia and cardiac events in high‑risk vascular patients【3】.

Elderly Patients (≥65 years)

• Anemia prevalence is ≈11 % in elderly men and 10.2 % in elderly women, underscoring the importance of routine pre‑operative screening【1】【2】.

Anemia Evaluation and Correction

Laboratory Evaluation (when hemoglobin below target)

• Order complete iron studies (serum iron, ferritin, transferrin saturation, total iron‑binding capacity)【1】【2】.
• Check vitamin B12 and folate levels; deficiencies occur in ≈12 % (B12) and 3 % (folate) of surgical patients【2】.
• Assess renal function (creatinine, estimated GFR) to identify chronic kidney disease【1】【2】.
• Evaluate for chronic inflammatory disease using CRP and ESR【1】【2】.

Etiology‑Specific Treatment

• Iron‑deficiency anemia accounts for ≈33 % of anemic surgical patients; address with appropriate iron therapy【2】.
• Nutritional deficiencies (B12, folate) should be corrected before surgery【1】【2】.
• For anemia of chronic disease/inflammation, consider erythropoiesis‑stimulating agents after ruling out/ correcting nutritional deficiencies (Grade 2A recommendation)【1】【2】.

Re‑assessment

• Re‑measure hemoglobin after treatment to confirm adequate response before proceeding with surgery【1】【2】.

Clinical Impact of Pre‑operative Anemia

• Pre‑operative anemia independently increases peri‑operative morbidity and mortality, irrespective of whether transfusion is required【1】【2】.
• Estimated intra‑operative blood loss > 500 mL markedly raises mortality risk regardless of pre‑operative hemoglobin, highlighting the need for meticulous surgical technique and blood‑conservation strategies【1】【2】.
• Post‑operative anemia is linked to longer hospital stays and impaired functional recovery, especially after orthopedic procedures【3】.

Preoperative Assessment Guidelines for Elective Hernia Repair

Hemoglobin and Anemia Management

Coagulation and Platelet Assessment

Renal Function Evaluation

Calcium Abnormalities

Metabolic Screening

Infection, Nutrition, and Immunosuppression

Preoperative Anemia Screening and Management Guidelines

Screening Timing and Hemoglobin Targets

Diagnostic Evaluation When Anemia Is Detected

Treatment of Identified Deficiencies

Use of Erythropoiesis‑Stimulating Agents (ESAs)

Renal‑Related Anemia Management

Re‑assessment Prior to Surgery

Epidemiology of Preoperative Anemia

Conceptual Importance

Hemoglobin Management Guidelines for Surgical Patients

Pre‑operative Hemoglobin Thresholds

• For elective surgeries, aim for a pre‑operative hemoglobin ≥ 13 g/dL in men and ≥ 12 g/dL in women, measured at least 28 days before the operation to allow anemia correction; patients with cardiovascular disease require a minimum hemoglobin ≥ 10 g/dL, and emergency procedures may proceed safely with hemoglobin as low as 6 g/dL if anticipated blood loss is < 500 mL【13】.
• Hemoglobin screening should be performed ≥ 28 days before elective surgery to provide sufficient time for diagnostic work‑up and treatment of identified anemia【13】.

Risk Stratification by Surgical Blood Loss

Low‑ to Moderate‑Risk Surgery (expected blood loss < 500 mL)

• Target hemoglobin ≥ 13 g/dL in men and ≥ 12 g/dL in women before granting surgical clearance【13】.

High‑Risk Surgery (expected blood loss > 500 mL)

• Maintain the same pre‑operative hemoglobin targets (≥ 13 g/dL men, ≥ 12 g/dL women) to optimize outcomes【13】.
• Blood loss exceeding 500 mL significantly increases mortality regardless of the pre‑operative hemoglobin level, underscoring the need for meticulous surgical technique【13】.

Patients with Cardiovascular Disease

• Require a pre‑operative hemoglobin ≥ 10 g/dL for all individuals with coronary artery disease, heart failure, or peripheral vascular disease【13】.
• Hemoglobin levels of 6–9 g/dL in this population are associated with a 12.3‑fold higher mortality risk compared with hemoglobin > 12 g/dL; the same range confers only a 1.4‑fold increase in patients without cardiovascular disease【13】.
• A hematocrit < 28 % (approximately hemoglobin < 9.3 g/dL) is significantly linked to peri‑operative myocardial ischemia and cardiac events in high‑risk vascular patients【13】.

Intra‑operative Transfusion Guidelines

• Patients without cardiovascular disease who are hemodynamically stable should receive a red‑cell transfusion when hemoglobin falls below 7 g/dL【14】【15】.
• Patients with cardiovascular disease should be transfused when hemoglobin is ≤ 8 g/dL or when they develop symptoms such as chest pain, orthostatic hypotension, tachycardia unresponsive to fluids, or congestive heart failure【14】【15】.
• Transfuse one unit of packed red blood cells at a time and reassess clinical status and hemoglobin before administering additional units【14】.

Emergency and Urgent Procedures

• Surgery may proceed with hemoglobin ≥ 6 g/dL if expected blood loss is < 500 mL, provided meticulous technique is used to minimize bleeding【13】.
• Maintaining normovolemia during surgery is essential, as hypovolemic anemia markedly impairs cardiovascular compensatory mechanisms【13】.

Common Pitfalls to Avoid

• Do not schedule elective surgery in anemic patients without first investigating and treating the underlying cause, as untreated pre‑operative anemia independently raises peri‑operative morbidity and mortality【13】.
• Do not assume all patients tolerate the same absolute hemoglobin threshold; baseline hemoglobin and cardiovascular reserve critically modify tolerance【13】.
• Do not rely solely on hemoglobin values; also assess hemodynamic stability, signs of end‑organ ischemia, and expected blood loss【15】.
• Do not transfuse to a pre‑operative hemoglobin > 10 g/dL; liberal transfusion strategies confer no benefit and increase complications【14】.
• Do not overlook subtle indicators of inadequate oxygen delivery (e.g., tachycardia unresponsive to fluids, elevated lactate, reduced urine output)【13】.

Outcomes Associated with Peri‑operative Anemia

• Post‑operative anemia is linked to longer hospital stays and impaired functional recovery, especially after orthopedic procedures【13】.
• Anemia prevalence among elective surgical patients ranges from 30 % to 40 %; up to 35 % of orthopedic surgery patients have hemoglobin < 13 g/dL【13】.

Preoperative Management of Anemia in Elective Surgery

Hemoglobin Assessment and Targets

• Screen hemoglobin at least 28 days before the scheduled elective procedure to allow sufficient time for diagnostic work‑up and correction of any identified anemia 16
• Require pre‑operative hemoglobin ≥13 g/dL for men and ≥12 g/dL for women (WHO normal range) before granting surgical clearance; this applies to both low‑risk (expected blood loss < 500 mL) and high‑risk (expected blood loss > 500 mL) surgeries 16

Diagnostic Work‑up When Anemia Is Detected

• Order a comprehensive laboratory panel immediately when hemoglobin falls below target values, including complete blood count, iron studies, renal function tests, and inflammatory markers 16
• Assess iron status with serum ferritin and transferrin saturation (TSAT):
  
  • Ferritin < 30 ng/mL and/or TSAT < 20 % indicates absolute iron deficiency.
  • Ferritin 30–100 ng/mL with TSAT < 20 % suggests functional iron deficiency or anemia of chronic disease. 17
• Measure serum creatinine and estimated glomerular filtration rate (eGFR) to identify chronic kidney disease as a potential cause of anemia [16][17]
• Obtain a reticulocyte count when the etiology of anemia remains unclear 17
• Refer to gastro‑enterology if iron deficiency is confirmed to evaluate for occult gastrointestinal blood loss 17
• Refer to nephrology if abnormal creatinine or eGFR indicates chronic kidney disease 17

Treatment Recommendations

• Correct identified vitamin B12 or folate deficiencies with appropriate supplementation once the deficiency is confirmed 16
• Use erythropoiesis‑stimulating agents (ESAs) after ruling out or correcting nutritional deficiencies (Grade 2A recommendation) for anemia of chronic disease or inflammation 16
• Provide iron supplementation (oral or intravenous) throughout ESA therapy to optimize dose‑response and red‑cell production 17

Clinical Perspective

• Anemia should be regarded as a serious, treatable medical condition rather than merely an abnormal laboratory value [16][17]